| Trial Identifier: | ALXN1210-PNH-401 |
| Sponsor: | Alexion Pharmaceuticals |
| Start Date: | March 2021 |
| Primary Completion Date: | December 2022 |
| Study Completion Date: | December 2022 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Plain Language Summary | |
| English (United Kingdom) Translation |
| Country | Location |
|---|---|
| United Kingdom | Leeds, United Kingdom, LS9 7TF |
| United Kingdom | London, United Kingdom, SE5 9RS |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company